5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. (November 2018)
- Record Type:
- Journal Article
- Title:
- 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. (November 2018)
- Main Title:
- 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity
- Authors:
- Gagnon, K.J.
Lefort, N.
Poirier, S.J.
Barnett, D.A.
Surette, M.E. - Abstract:
- Highlights: 5-lipoxygenase (5-LO) catalyzes the conversion of 20:4 n-3 into novel oxygenated metabolites. Metabolites identified as Δ 17 -8‑hydroxy‑eicosatetraenoic acid (Δ 17 -8-HETE) and Δ 17 -8, 15-dihydroxy-eicosatetraenoic acid (Δ 17 -8, 15-diHETE). Δ 17 -8, 15-diHETE biosynthesis is inhibited by LTA4 hydrolase inhibitor SC 57461A. Δ 17 -8, 15-diHETE inhibits arachidonic acid-induced autocrine neutrophil stimulation and LTB4 -induced neutrophil chemotaxis. Abstract: 5-lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into pro-inflammatory leukotrienes. N-3 PUFA like eicosapentaenoic acid are subject to a similar metabolism and are precursors of pro-resolving mediators. Stearidonic acid (18:4 n-3, SDA) is a plant source of n-3 PUFA that is elongated to 20:4 n-3, an analogue of AA. However, no 5-LO metabolites of 20:4 n-3 have been reported. In this study, control and 5-LO-expressing HEK293 cells were stimulated in the presence of 20:4 n-3. Metabolites were characterized by LC-MS/MS and their anti-inflammatory properties assessed using AA-induced autocrine neutrophil stimulation and leukotriene B4 -mediated chemotaxis. 8‑hydroxy‑9, 11, 14, 17-eicosatetraenoic acid (Δ 17 -8-HETE) and 8, 15-dihydroxy-9, 11, 13, 17-eicosatetraenoic acid (Δ 17 -8, 15-diHETE) were identified as novel metabolites. Δ 17 -8, 15-diHETE production was inhibited by the leukotriene A4 hydrolase inhibitor SC 57461A. Autocrine neutrophil leukotriene stimulation and neutrophilHighlights: 5-lipoxygenase (5-LO) catalyzes the conversion of 20:4 n-3 into novel oxygenated metabolites. Metabolites identified as Δ 17 -8‑hydroxy‑eicosatetraenoic acid (Δ 17 -8-HETE) and Δ 17 -8, 15-dihydroxy-eicosatetraenoic acid (Δ 17 -8, 15-diHETE). Δ 17 -8, 15-diHETE biosynthesis is inhibited by LTA4 hydrolase inhibitor SC 57461A. Δ 17 -8, 15-diHETE inhibits arachidonic acid-induced autocrine neutrophil stimulation and LTB4 -induced neutrophil chemotaxis. Abstract: 5-lipoxygenase (5-LO) catalyzes the conversion of arachidonic acid (AA) into pro-inflammatory leukotrienes. N-3 PUFA like eicosapentaenoic acid are subject to a similar metabolism and are precursors of pro-resolving mediators. Stearidonic acid (18:4 n-3, SDA) is a plant source of n-3 PUFA that is elongated to 20:4 n-3, an analogue of AA. However, no 5-LO metabolites of 20:4 n-3 have been reported. In this study, control and 5-LO-expressing HEK293 cells were stimulated in the presence of 20:4 n-3. Metabolites were characterized by LC-MS/MS and their anti-inflammatory properties assessed using AA-induced autocrine neutrophil stimulation and leukotriene B4 -mediated chemotaxis. 8‑hydroxy‑9, 11, 14, 17-eicosatetraenoic acid (Δ 17 -8-HETE) and 8, 15-dihydroxy-9, 11, 13, 17-eicosatetraenoic acid (Δ 17 -8, 15-diHETE) were identified as novel metabolites. Δ 17 -8, 15-diHETE production was inhibited by the leukotriene A4 hydrolase inhibitor SC 57461A. Autocrine neutrophil leukotriene stimulation and neutrophil chemotaxis, both BLT1-dependent processes, were inhibited by Δ 17 -8, 15-diHETE at low nM concentrations. These data support an anti-inflammatory role for Δ 17 -8, 15-diHETE, a novel 5-LO product. … (more)
- Is Part Of:
- Prostaglandins, leukotrienes, and essential fatty acids. Volume 138(2018)
- Journal:
- Prostaglandins, leukotrienes, and essential fatty acids
- Issue:
- Volume 138(2018)
- Issue Display:
- Volume 138, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 138
- Issue:
- 2018
- Issue Sort Value:
- 2018-0138-2018-0000
- Page Start:
- 38
- Page End:
- 44
- Publication Date:
- 2018-11
- Subjects:
- Leukotrienes -- Lipid mediators -- Inflammation -- Neutrophils -- Eicosanoids
Abbreviations: 19-OH-PGB2, 19(R)-hydroxy-prostaglandin B2 -- AA, arachidonic acid -- ADA, adenosine deaminase -- ALA, alpha-linolenic acid -- BLT1, leukotriene B4 receptor 1 -- DHA, docosahexaenoic acid -- DPA, docosapentaenoic acid -- ETA, eicosatetraenoic acid -- EtOH, ethanol -- HpETE, hydroperoxyeicosatetraenoic acid -- LO, lipoxygenase -- LTA4, leukotriene A4 -- LTB4, leukotriene B4 -- LTC4, leukotriene C4 -- MeOH, methanol -- NEM, N-ethylmaleimide -- RP-HPLC, reverse phase-HPLC -- SDA, stearidonic acid
Lipids -- Periodicals
Unsaturated fatty acids -- Periodicals
Prostaglandins -- Periodicals
Leukotrienes -- Periodicals
Fatty Acids, Unsaturated -- Periodicals
Acides gras insaturés -- Périodiques
Prostaglandines -- Périodiques
Leucotriènes -- Périodiques
Lipides -- Périodiques
612.01577 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09523278 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09523278 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09523278 ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.plefa.2018.10.005 ↗
- Languages:
- English
- ISSNs:
- 0952-3278
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.190900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14562.xml